A scoping review of the distribution and frequency of extended-spectrum β -lactamase (ESBL)-producing Enterobacteriaceae in shrimp and salmon.
Kaitlin M YoungM J IsadaM ReistF Carl UhlandL M SherkCarolee A CarsonPublished in: Epidemiology and infection (2022)
Antimicrobial-resistant (AMR) bacteria are a threat to public health as they can resist treatment and pass along genetic material that allows other bacteria to become drug-resistant. To assess foodborne AMR risk, the Codex Guidelines for Risk Analysis of Foodborne AMR provide a framework for risk profiles and risk assessments. Several elements of a risk profile may benefit from a scoping review (ScR). To contribute to a larger risk profile structured according to the Codex Guidelines, our objective was to conduct a ScR of the current state of knowledge on the distribution, frequency and concentrations of extended-spectrum β -lactamase (ESBL)-producing Enterobacteriaceae in salmon and shrimp. Articles were identified via a comprehensive search of five bibliographic databases. Two reviewers screened titles and abstracts for relevance and characterised full-text articles with screening forms developed a priori . Sixteen relevant studies were identified. This review found that there is a lack of Canadian data regarding ESBL-producing Enterobacteriaceae in salmon and shrimp. However, ESBL- producing Escherichia coli , Klebsiella pneumoniae and other Enterobacteriaceae have been isolated in multiple regions with a history of exporting seafood to Canada. The literature described herein will support future decision-making on this issue as research/surveillance and subsequent assessments are currently lacking.
Keyphrases
- klebsiella pneumoniae
- escherichia coli
- multidrug resistant
- drug resistant
- public health
- pseudomonas aeruginosa
- decision making
- healthcare
- acinetobacter baumannii
- staphylococcus aureus
- gene expression
- machine learning
- big data
- urinary tract infection
- cystic fibrosis
- antimicrobial resistance
- copy number
- replacement therapy
- case control